Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Theodor

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
British Journal of Cancer|July 17, 1998
An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi JewsL Theodor, R Bar-Sade, A Kruglikova, et al.
Harefuah|July 27, 2000
[Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer]L Theodor, R Shiri-Sverdlov, G H Yechezkel, et al.
JAMA|December 11, 1996
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian CancerB Modan, E Gak, R B Sade-Bruchim, et al.
Human Molecular Genetics|May 23, 1998
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to AshkenazimR B Bar-Sade, A Kruglikova, B Modan, et al.
Clinical and Experimental Medicine|November 5, 2003
Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat testsA Augarten, H Berman, M Aviram, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
British Journal of Cancer|July 17, 1998
An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi JewsL Theodor, R Bar-Sade, A Kruglikova, et al.
Harefuah|July 27, 2000
[Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer]L Theodor, R Shiri-Sverdlov, G H Yechezkel, et al.
JAMA|December 11, 1996
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian CancerB Modan, E Gak, R B Sade-Bruchim, et al.
Human Molecular Genetics|May 23, 1998
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to AshkenazimR B Bar-Sade, A Kruglikova, B Modan, et al.
Clinical and Experimental Medicine|November 5, 2003
Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat testsA Augarten, H Berman, M Aviram, et al.
Pageof 3